实验数据对药物领域专利申请的影响与分析  

The influence and analysis of the experimental evidence for patent application in pharmaceutical field

作　　者：邢维伟[1] 周卓 XING Wei-wei;ZHOU Zhuo(Patent Office of the State Intellectual Property Office,Beijing 100088,China;China National Pharmaceutical Group Corporation,Beifing 100191,China)

机构地区：[1]国家知识产权局专利局,北京100088 [2]中国医药集团有限公司,北京100191

出　　处：《中国新药杂志》2018年第18期2143-2147,共5页Chinese Journal of New Drugs

摘　　要：在药物领域的专利申请中,实验数据是非常关键的内容之一,与申请的专利性直接相关。本文对药物领域专利申请文件中实验数据记载的必要性、作用和程度,以及对申请日之后的补充实验数据的效力进行了全面分析和案例说明,为申请人在药品相关专利的开发布局中,对专利申请中必要的数据研究提供借鉴和参考。The experimental evidence is an important part of the patent application in pharmaceutical field and determines the patentability directly. The necessity,action and extent of the experimental evidence and the effectiveness of the supplemental experimental evidence which submitted after the filling date are analysed and illustrated with cases in this article. The article can provide reference and guidance about indispensable experimental evidence for applictants in the development of their patent applicantions.

关 键 词：药物专利 公开不充分 创造性 实验数据 

分 类 号：R95[医药卫生—药学]